SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Sep 2021 07:00

RNS Number : 4571N
Numis Corporation PLC
30 September 2021
 

Numis Corporation Plc ("Numis")

Trading Update

30 September 2021

 

Thursday, 30 September 2021 at 7.00am: Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the year ending 30 September 2021.

Numis maintained its positive momentum and delivered a strong performance in the final quarter of the financial year. Whilst there was an anticipated pause in IPO activity and more subdued markets in general over the summer period, this was offset by the completion of a number of significant M&A transactions involving Numis in a lead advisory capacity. Revenue for the second half will exceed the level achieved in the second half of FY20 which featured a significant volume of COVID related capital markets transactions. Full year revenue is expected to be in the region of £215m (FY20: £154.9m), with the benefit of operational gearing leading to profits significantly higher than the prior year (FY20 PBT: £37.1m).

Investment Banking revenues have grown significantly and will be in excess of £150m for the year (FY20: £101.7m). Alongside market share gains in our core UK capital markets business, we have seen material revenue contributions from M&A and private markets transactions. In addition we are increasingly able to leverage our UK track record and reputation in new markets. As a result, in the past year we have acted on a number of capital markets transactions, both public and private, for non-UK issuers, most notably in the digital consumer and fintech sectors. During the second half we continued to selectively invest in talent, to both increase the capacity of the Investment Banking platform and broaden our capabilities.

Equities delivered a strong second half performance, although lower than the exceptional performance achieved in the first half. Given the favourable market backdrop we increased the capital allocated to our trading books and delivered good, and consistent, trading profits throughout year. Institutional income is ahead of the prior year underpinned by resilient research payments, market share gains and good activity levels in UK equities. 

Our pipeline remains very strong, and the wider market outlook for Numis is positive. We expect to launch a number of IPOs in the coming weeks, the capital raising environment is active across both public and private markets, and UK M&A is likely to remain at elevated levels as we emerge from the pandemic. Our strategy to build a more diversified, yet agile, investment banking business has contributed to an excellent year for Numis. We have recently completed the move to our new headquarters at 45 Gresham Street and we look forward to continuing on our strategic path supported by our exceptional colleagues.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

 

Contacts

Numis:

Noreen Biddle-Shah, Head of Corporate Communications 020 7260 1441 

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Harrison Clarke 020 7184 4384

Lukas Girzadas 020 7865 2850

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and has offices in London and New York.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKAWRABUKUAR
Date   Source Headline
20th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Mar 201811:06 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20183:00 pmRNSDirectors' Dealing
9th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20184:00 pmRNSDirector's Dealing
23rd Feb 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20182:13 pmRNSHolding(s) in Company
15th Feb 201812:45 pmRNSHolding(s) in Company
13th Feb 20181:41 pmRNSHolding(s) in Company
13th Feb 201811:28 amRNSHolding(s) in Company
6th Feb 20181:17 pmRNSResult of AGM
6th Feb 20187:00 amRNSTrading update
5th Feb 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jan 201812:00 pmRNSDirectors' Dealing
16th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jan 20187:00 amRNSBoard Change
5th Jan 20189:14 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20187:00 amRNSAnnual Report and Annual General Meeting Notice
13th Dec 20173:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
6th Dec 20177:00 amRNSPreliminary Results for the year ended 30 Sep 2017
29th Nov 20174:28 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 201711:32 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20177:32 amRNSTrading Update
29th Sep 20177:00 amRNSPurchase of Shares in Close Period
21st Sep 20177:00 amRNSCancellation of Share Premium Account
20th Sep 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20173:00 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSDirector's Dealing
12th Sep 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20174:32 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20174:34 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 201711:09 amRNSHolding(s) in Company
1st Sep 20172:24 pmRNSHolding(s) in Company
1st Sep 20172:23 pmRNSDirector's Dealing
1st Sep 201712:26 pmRNSTransaction in Own Shares and Total Voting Rights
30th Aug 201711:00 amRNSResult of General Meeting
11th Aug 20171:00 pmRNSNotice of Meeting and Proposed Capital Reduction
9th Aug 20173:34 pmRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jul 20177:01 amRNSBoard Changes
28th Jul 20177:00 amRNSTrading Update
13th Jul 201711:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.